397246-14-9

Basic information

• Product Name: (R)-(+)-2-(Boc-Amino)-1,4-butanediol
• Synonyms: Carbamic acid, [(1R)-3-hydroxy-1-(hydroxymethyl)propyl]-, 1,1-dimethylethyl;(R)-TERT-BUTYL 1,4-DIHYDROXYBUTAN-2-YLCARBAMATE;(2R)-(tert-Butoxycarbonylamino)butane-1,4-diol;(R)-(+)-2-(Boc-Amino)-1,4-butanediol;[(1R)-3-Hydroxy-1-(hydroxymethyl)propyl]carbamic acid tert-butyl ester;(R)-2-Boc-amino-butane-1,4-diol;-tert-Butyl (1,4-dihydroxybutan-2-yl)
• CAS NO: 397246-14-9
• Molecular Formula: C₉H₁₉NO₄
• Molecular Weight: 205.25
• EINECS: 210-006-7
• Product Categories: N-BOC;API intermediates;Chiral Compounds
• Mol File: 397246-14-9.mol
• Article Data: 10

Chemical Properties

• Melting Point: 64-68 °C
• Boiling Point: 365.041 °C at 760 mmHg
• Flash Point: 174.571 °C
• Appearance: White/Crystalline Powder
• Density: 1.110
• Vapor Pressure: 0mmHg at 25°C
• Refractive Index: 1.476
• Storage Temp.: 2-8°C
• PKA: 11.81±0.46(Predicted)
• CAS DataBase Reference: (R)-(+)-2-(Boc-Amino)-1,4-butanediol(CAS DataBase Reference)
• NIST Chemistry Reference: (R)-(+)-2-(Boc-Amino)-1,4-butanediol(397246-14-9)
• EPA Substance Registry System: (R)-(+)-2-(Boc-Amino)-1,4-butanediol(397246-14-9)

Safety Data

• Hazardous Substances Data: 397246-14-9(Hazardous Substances Data)

Usage

Chemical Properties

White Solid

InChI:InChI=1/C9H19NO4/c1-9(2,3)14-8(13)10-7(6-12)4-5-11/h7,11-12H,4-6H2,1-3H3,(H,10,13)/t7-/m1/s1

Upstream product

• 67198-86-1 (R)-2-[(tert-butoxycarbonyl)amino]butano-4-lactone 
• 146514-35-4 (RS)-N-tert-butoxycarbonyl-α-amino-γ-butyrolactone 
• 428440-11-3 D-Boc-L-Asp(OEt)OEt 
• 130622-08-1 (2R)-2-tert-butoxycarbonylamino-succinic acid dimethyl ester 

Downstream Products

• 201404-86-6 tert-butyl (4R)-4-(2-hydroxyethyl)-2,2-dimethyl-1,3-oxazolidine-3-carboxylate 
• 153053-19-1 (4R)-2,2-dimethyl-4-(2-oxoethyl)-oxazolidine-3-carboxylic acid tert-butyl ester 
• 486460-00-8 (3R)-3-[(1,1-dimethylethoxycarbonyl)amino]-4-(2,4,5-trifluorophenyl)butanoic acid 
• 1048703-14-5 (R)-tert-butyl (4-hydroxy-1-(2,4,5-trifluorophenyl)butan-2-yl)carbamate 
• 869569-89-1 C₂₅H₃₇NO₄Si 
• 131878-23-4 (3R)-1-benzyl-3-[(tert-butoxycarbonyl)(methyl)amino]pyrrolidine 
• 122536-77-0 3-N-tert-butoxycarbonyl-3-(R)-aminopyrrolidine 

Relevant articles and documents

β-Hydroxy- A nd β-Aminophosphonate Acyclonucleosides as Potent Inhibitors of Plasmodium falciparum Growth

Malaria is an infectious disease caused by a parasite of the genus Plasmodium, and the emergence of parasites resistant to all current antimalarial drugs highlights the urgency of having new classes of molecules. We developed an effective method for the synthesis of a series of β-modified acyclonucleoside phosphonate (ANP) derivatives, using commercially available and inexpensive materials (i.e., aspartic acid and purine heterocycles). Their biological evaluation in cell culture experiments and SAR revealed that the compounds' effectiveness depends on the presence of a hydroxyl group, the chain length (four carbons), and the nature of the nucleobase (guanine). The most active derivative inhibits the growth of Plasmodium falcIParum in vitro in the nanomolar range (IC50 = 74 nM) with high selectivity index (SI > 1350). This compound also showed remarkable in vivo activity in P. berghei-infected mice (ED50 ～0.5 mg/kg) when administered by the IP route and is, although less efficient, still active via the oral route. It is the first ANP derivative with such potent antimalarial activity and therefore has considerable potential for development as a new antimalarial drug.

Preparation method of sitagliptin intermediate

The invention discloses a preparation method of a sitagliptin intermediate and belongs to the field of medicine synthesis. The invention provides a preparation method of a compound 2; the compound 2 is prepared without the need of a catalyst and a resolving agent which have a high price and harsh low-temperature conditions, so that the cost is reduced to the great extent; the preparation method has the advantages of simple technology, high purity and high yield and is suitable for mass production.

CERTAIN CHEMICAL ENTITIES, COMPOSITIONS, AND METHODS

Compounds useful for treating cellular proliferative diseases and disorders by modulating the activity of one or more mitotic kinesins are disclosed.